Apogee Therapeutics, Inc. · NASDAQ:APGE

Dambkowski Carl sold 5,500 Apogee Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 3, 2026

On Apr 1, 2026, Dambkowski Carl (Chief Medical Officer) sold 5,500 Apogee Therapeutics, Inc. shares at an average US$84.84 for US$467K under a trading plan, leaving 208,398 shares. Filed Apr 3, 2026 (Form 4).

Sold
5,500 shares
Price
US$84.84 average (US$84.31 to US$85.89)
Value
US$467K
Holding after
208,398 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockOption exercise4,125US$22.86213,898Direct
Apr 1, 2026Common StockSale2,698US$84.31211,200Direct
Apr 1, 2026Common StockSale2,702US$85.33208,498Direct
Apr 1, 2026Common StockSale100US$85.89208,398Direct

Source

View original at SEC

Related